Search Results

You searched for : Abbvie  

Bhopal Hosts Third State-Level Consultation on Glaucoma Prevention

A panel discussion followed which brought together specialists who discussed various approaches to managing glaucoma, followed by an interactive Q&A session where attendees had ...
Sep 23

Sightsavers India and AbbVie India Hosted a State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’ in Lucknow

The consultation also featured a free glaucoma screening session for attendees aged 40 and above, led by Dr Suneeta Dubey and her team, ensuring participants ...
Aug 26

Sightsavers India and AbbVie India Host Successful State-Level Consultation on Glaucoma Awareness

A highlight of the event was the glaucoma screening offered to attendees aged 40 and above, ensuring that participants had access to immediate and practical ...
Jun 29

AbbVie India and Sightsavers India Collaborate to Raise Awareness on Glaucoma

...
May 02

AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research

Latest pharma news updates...
Nov 12

AbbVie, Eisai, and EA Pharma launch “Humira support tool ordering service for Patients”

Latest pharma news update...
Sep 16

Mission and AbbVie collaboration in Alzheimer’s and Parkinson’s diseases reaches next milestone

Latest Pharma News Update...
Aug 10

AbbVie and Calico announce Second Extension of collaboration focused on aging and age-related Diseases

Latest Pharma Update...
Jul 30

Top pharma stocks for long term investing : The companies to watch for in next 5 years

The pharma stocks for long term wealth creation ...
Jan 11

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Harbour BioMed, and Utrecht University today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the ...
Dec 15

I-Mab accelerates clinical development of anti-CD47 monoclonal antibody lemzoparlimab in the US and China

I-Mab's global collaboration with AbbVie will facilitate global development of lemzoparlimab...
Dec 05

AbbVie and Frontier Medicines establish global partnership for research and development

The partnership will address novel therapies and E3 Degraders against difficult-to-drug targets...
Dec 04

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Testosterone Gel

Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone....
Nov 25

Alembic Pharmaceuticals announces USFDA Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.

Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of US$ 17 million for twelve months ending June 2020 ...
Oct 21

AbbVie submits regulatory applications to US FDA and EMA for RINVOQ (upadacitinib) in atopic dermatitis

These submissions are an important step forward in the commitment to providing an additional treatment option ...
Oct 20

AbbVie received US FDA approval for the treatment of acute myeloid leukemia

...
Oct 17

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ...
Oct 14

Lupin Launches Divalproex Sodium ER Tablets USP

Pharma major Lupin Limited announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, after an approval by U....
Sep 22

ACTO acquires Scrimmage, disrupting Life Sciences learning and engagement market

ACTO cements its position as the largest life sciences commercial learning and development platform ...
Sep 15

AbbVie and I-Mab have collaborated for the treatment of multiple cancers

AbbVie and I-Mab enter Into global strategic partnership for differentiated immuno-oncology therapy ...
Sep 04

Positive phase 3 data for atogepant in migraine prevention

AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant in migraine prevention...
Jul 31

AbbVie submits regulatory applications to FDA and EMA for RINVOQ

RINVOQ will be used for the treatment of adults with Active Psoriatic Arthritis...
Jun 08

BioMed X Institute launches Rapid Antiviral Response Platform for pandemics

BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany. ...
May 18

Scientists Create Antibody That Defeats Coronavirus in Lab

The experimental antibody has neutralized the virus in cell cultures. While that's early in the drug development process, the antibody may help prevent or ...
May 05

25 Matching result(s) found!

-Advertisements-




Trending Now

GET WEDDING-READY WITH KAY BEAUTY: KATRINA KAIF’S TOP PICKS FOR BRIDES & BRIDESMAIDSNovember 11, 2024
Amrita Vishwa Vidyapeetham Students Win Global All-Track Grand Prize at HackHarvard 2024 Organized by Harvard University StudentsNovember 11, 2024
Algorand Foundation Announces its Investment in 5 Startups from the Inaugural Startup Lab Program at T-HubNovember 11, 2024
DOST, DTI & DICT join forces for Philippine Startup Week 2024 to Ignite Filipino InnovationNovember 11, 2024
Firewall gender equality from threats like anti-rights Geneva Consensus DeclarationNovember 11, 2024
Delhi’s Air Crisis: How Toxic Air and Pollution Are Still Threatening Health and Life QualityNovember 11, 2024
Are You at Risk? AI Data Exposes Unseen Triggers of Diabetes in Our EnvironmentNovember 11, 2024
Why Children in High-Risk Areas Are Paying the Price for TB Neglect?November 11, 2024
The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening InfectionsNovember 09, 2024
Is Your Gut Telling You Something? The Bacterial Clues to Early Rheumatoid ArthritisNovember 09, 2024
Newcastle University Announces VC Excellence Scholarships for Undergraduate and Postgraduate StudiesNovember 08, 2024
Beyond the X-ray: Celebrating the Pioneers of Radiography on World Radiography DayNovember 08, 2024
Digital Doctors and Village Heroes: Tackling Depression and Stigma in India’s HeartlandNovember 08, 2024
Why Are Food Giants Pushing ‘Low-Star’ Nutrition on Low-Income Countries?November 08, 2024
NokAir joins hands with Çelebi for world class ground handling services for newly launched Bangkok-Mumbai routeNovember 07, 2024
Why Are Rare Disease Patients Paying a Fortune When Local Production Could Save Lives?November 07, 2024
Building Lips in the Lab: How Scientists Are Growing Lab Lips to Heal and RebuildNovember 07, 2024
National Cancer Awareness Day: How Small Changes Today Can Save Lives TomorrowNovember 07, 2024
Introducing an AI tool for accurate diagnosis of cholelithiasis on abdominal CT scansNovember 06, 2024
Nat Habit Unveils New Chapter of “Breathe Life Into Your Beauty” Campaign championed by Content Creators and the Launch of VeDHA, digital skin analysis toolNovember 06, 2024